The Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications of Genetics and Genomics

下一代测序等基因组技术的快速发展正在改变 我们对人类健康和人类历史的理解。这些技术还承诺 前所未有的权力，干预个人的身体或处于疾病的风险，和 甚至改变还未出生的个体的身份或未来。这样的知识和力量 这意味着以促进核心道德价值观的方式利用它们， 个人和集体福利、社会正义、保护弱势群体以及对两者的尊重 个人的自主权和社区的利益。履行这些职责 需要一个多样化的，训练有素的，跨学科的学者准备从事干部 以批判和尊重的态度对待遗传学带来的深刻的伦理、法律的和社会挑战， 和基因组技术。为了满足这一需求，宾夕法尼亚大学的基本目标是 遗传学的伦理、法律的和社会影响（ELSI）博士后培训计划 和基因组学是准备学员成功的创造性，独立的调查人员在 ELSI研究领域。该计划，设在医学伦理学系， 佩雷尔曼医学院的健康政策将通过两个核心目标实现这一目标。 组成部分：1）完成医学伦理学硕士（MSME）学位， 生物伦理学概念、经验方法和遗传科学方面的培训，以及2）指导 原创性研究，导致高影响力的经验和概念的学术出版物。一个 优秀的课程教师，由12位经验丰富的ELSI学者和导师组成， 佩雷尔曼医学院、艺术与科学学院和宾夕法尼亚大学的各部门 法学院，将担任导师，以计划学员。学员将出席及 参与医学伦理和健康政策部门的每月工作进展 和研讨会系列，参加广泛的研讨会和会议在整个大学 侧重于遗传医学和科学以及伦理学、法律、经济学和健康 政策，并出席国家会议。学员还将接触遗传医学 通过跟踪专家遗传学家和顾问从全方位的成年人， 儿科和生殖遗传学实践。最后，受训人员将担任 宾夕法尼亚大学机构审查委员会（IRB）审查ELSI相关研究。程序 将培养七名博士后学者，每人将参加三年，并将 通过广泛的有针对性的培训， 与不同学术团体的联系。

Rapid advances in genomic technologies such as next-generation sequencing are transforming our understandings of both human health and human history. These technologies also promise unprecedented power to intervene on the bodies of individuals with or at risk of disease, and even to alter the identities or futures of individuals not yet born. Such knowledge and power imply immense responsibility to use them in ways that promote core ethical values, including individual and collective welfare, social justice, protection of the vulnerable, and respect for both the autonomy of persons and the interests of communities. Fulfilling these responsibilities requires a cadre of diverse, highly trained, interdisciplinary scholars prepared to engage critically and respectfully with the profound ethical, legal and social challenges raised by genetic and genomic technologies. Responding to this need, the fundamental goal of the Penn Postdoctoral Training Program in the Ethical, Legal and Social Implications (ELSI) of Genetics and Genomics is to prepare trainees for success as creative, independent investigators in the field of ELSI research. The program, housed within the Department of Medical Ethics and Health Policy at the Perelman School of Medicine, will achieve this goal through two core components: 1) completion of a Master of Science in Medical Ethics (MSME) degree that blends training in conceptual bioethics, empirical methods and genetic science, and 2) mentored original research leading to high-impact empirical and conceptual scholarly publications. An outstanding program faculty, consisting of 12 experienced ELSI scholars and mentors from departments at the Perelman School of Medicine, the School of Arts and Sciences and the Penn Law School, will serve as preceptors to program trainees. Trainees will present at and participate in the Department of Medical Ethics and Health Policy's monthly works-in-progress and seminar series, attend a wide range of seminars and conferences across the University focused on genetic medicine and science as well as on ethics, law, economics and health policy, and present at national meetings. Trainees will also gain exposure to genetic medicine through shadowing expert geneticists and counselors drawn from the full spectrum of adult, pediatric and reproductive genetics practice. Finally, trainees will serve as members of one of the UPenn institutional review boards (IRBs) that review ELSI-related research. The program will train seven postdoctoral scholars, each of whom will participate for three years, and will ensure diversity of discipline and background among enrolled trainees by extensive targeted outreach to diverse academic communities.